

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.67074117 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.38949958 |
| 3 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.04329142 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.96603037 |
| 5 | tolerance induction (GO:0002507) | 4.91246809 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.65107022 |
| 7 | neutrophil activation (GO:0042119) | 4.46977135 |
| 8 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.41802386 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.41244403 |
| 10 | granulocyte activation (GO:0036230) | 4.30046066 |
| 11 | myeloid dendritic cell differentiation (GO:0043011) | 4.14490913 |
| 12 | response to peptidoglycan (GO:0032494) | 4.09027732 |
| 13 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.03622808 |
| 14 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.02970404 |
| 15 | regulation of activation of Janus kinase activity (GO:0010533) | 4.02698965 |
| 16 | T cell migration (GO:0072678) | 4.00655617 |
| 17 | positive thymic T cell selection (GO:0045059) | 3.98998859 |
| 18 | response to muramyl dipeptide (GO:0032495) | 3.98723789 |
| 19 | response to interleukin-15 (GO:0070672) | 3.96944084 |
| 20 | myeloid dendritic cell activation (GO:0001773) | 3.96802595 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 3.95826428 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 3.95315460 |
| 23 | positive regulation of interleukin-12 production (GO:0032735) | 3.93269953 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.86194867 |
| 25 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.81824961 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.80664723 |
| 27 | positive regulation of type 2 immune response (GO:0002830) | 3.77501961 |
| 28 | positive T cell selection (GO:0043368) | 3.76901789 |
| 29 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.74095440 |
| 30 | thymic T cell selection (GO:0045061) | 3.72481862 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72252680 |
| 32 | T cell selection (GO:0045058) | 3.70159809 |
| 33 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.68014821 |
| 34 | regulation of regulatory T cell differentiation (GO:0045589) | 3.60867490 |
| 35 | detection of other organism (GO:0098543) | 3.60708181 |
| 36 | T-helper 1 type immune response (GO:0042088) | 3.59528541 |
| 37 | positive regulation of interleukin-2 production (GO:0032743) | 3.59025336 |
| 38 | positive regulation of interferon-alpha production (GO:0032727) | 3.58345501 |
| 39 | detection of bacterium (GO:0016045) | 3.57082551 |
| 40 | regulation of tolerance induction (GO:0002643) | 3.56925583 |
| 41 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.54939499 |
| 42 | negative regulation of cell killing (GO:0031342) | 3.54939499 |
| 43 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.52503344 |
| 44 | negative regulation of interleukin-12 production (GO:0032695) | 3.51639337 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.51403906 |
| 46 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.51280439 |
| 47 | negative thymic T cell selection (GO:0045060) | 3.51176201 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.50267632 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.47467880 |
| 50 | activated T cell proliferation (GO:0050798) | 3.46600694 |
| 51 | negative T cell selection (GO:0043383) | 3.46058051 |
| 52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43413908 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.43303012 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.42218389 |
| 55 | positive regulation of isotype switching (GO:0045830) | 3.41502169 |
| 56 | regulation of RIG-I signaling pathway (GO:0039535) | 3.41283516 |
| 57 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.40929217 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40815433 |
| 59 | regulation of interferon-alpha production (GO:0032647) | 3.40535993 |
| 60 | regulation of immunoglobulin secretion (GO:0051023) | 3.39962691 |
| 61 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.39458227 |
| 62 | cellular response to zinc ion (GO:0071294) | 3.38772247 |
| 63 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.38384915 |
| 64 | monocyte chemotaxis (GO:0002548) | 3.38192533 |
| 65 | type I interferon signaling pathway (GO:0060337) | 3.36624526 |
| 66 | cellular response to type I interferon (GO:0071357) | 3.36624526 |
| 67 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.36171481 |
| 68 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.36087201 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.36087201 |
| 70 | superoxide anion generation (GO:0042554) | 3.34815630 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.34002783 |
| 72 | response to type I interferon (GO:0034340) | 3.33906236 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.32581598 |
| 74 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.31389182 |
| 75 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.29727892 |
| 76 | positive regulation of B cell mediated immunity (GO:0002714) | 3.29727892 |
| 77 | interferon-gamma production (GO:0032609) | 3.28756424 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.25703823 |
| 79 | defense response to protozoan (GO:0042832) | 3.25633724 |
| 80 | respiratory burst (GO:0045730) | 3.25485599 |
| 81 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.24369775 |
| 82 | regulation of B cell differentiation (GO:0045577) | 3.24055747 |
| 83 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.23971499 |
| 84 | eosinophil chemotaxis (GO:0048245) | 3.23566868 |
| 85 | dendritic cell chemotaxis (GO:0002407) | 3.23395319 |
| 86 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21966557 |
| 87 | regulation of hypersensitivity (GO:0002883) | 3.20874627 |
| 88 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.20284456 |
| 89 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.20246911 |
| 90 | cellular extravasation (GO:0045123) | 3.19762608 |
| 91 | positive regulation of DNA recombination (GO:0045911) | 3.18493032 |
| 92 | positive regulation of tolerance induction (GO:0002645) | 3.17051642 |
| 93 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.14354710 |
| 94 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.13788051 |
| 95 | natural killer cell mediated immunity (GO:0002228) | 3.13605130 |
| 96 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.13605130 |
| 97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13421442 |
| 98 | dendritic cell differentiation (GO:0097028) | 3.11402378 |
| 99 | regulation of interleukin-12 production (GO:0032655) | 3.10833063 |
| 100 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.08985443 |
| 101 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07816387 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.07292287 |
| 103 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.07292287 |
| 104 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.07292287 |
| 105 | modulation by symbiont of host immune response (GO:0052553) | 3.07292287 |
| 106 | positive regulation by symbiont of host defense response (GO:0052509) | 3.07292287 |
| 107 | modulation by symbiont of host defense response (GO:0052031) | 3.07292287 |
| 108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.06154289 |
| 109 | T-helper cell differentiation (GO:0042093) | 3.06154289 |
| 110 | leukocyte aggregation (GO:0070486) | 3.05066211 |
| 111 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.02007490 |
| 112 | positive regulation of B cell differentiation (GO:0045579) | 3.01298123 |
| 113 | positive regulation of response to biotic stimulus (GO:0002833) | 2.99584899 |
| 114 | T cell receptor signaling pathway (GO:0050852) | 2.99513701 |
| 115 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.99364651 |
| 116 | mast cell activation (GO:0045576) | 2.98779705 |
| 117 | positive regulation of mast cell degranulation (GO:0043306) | 2.98595554 |
| 118 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.98595554 |
| 119 | regulation of T-helper cell differentiation (GO:0045622) | 2.98450141 |
| 120 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.98239950 |
| 121 | regulation of chronic inflammatory response (GO:0002676) | 2.97830261 |
| 122 | negative regulation of innate immune response (GO:0045824) | 2.97513405 |
| 123 | positive regulation of humoral immune response (GO:0002922) | 2.97278036 |
| 124 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.97244981 |
| 125 | B cell homeostasis (GO:0001782) | 2.96710964 |
| 126 | regulation of cell killing (GO:0031341) | 2.96150235 |
| 127 | regulation of antigen processing and presentation (GO:0002577) | 2.93857846 |
| 128 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.93680448 |
| 129 | negative regulation of interleukin-17 production (GO:0032700) | 2.92860690 |
| 130 | dendritic cell migration (GO:0036336) | 2.91254585 |
| 131 | cellular response to interferon-beta (GO:0035458) | 2.90755625 |
| 132 | response to protozoan (GO:0001562) | 2.90398116 |
| 133 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.89876483 |
| 134 | germinal center formation (GO:0002467) | 2.89551224 |
| 135 | regulation of alpha-beta T cell activation (GO:0046634) | 2.88676295 |
| 136 | macrophage activation involved in immune response (GO:0002281) | 2.88172986 |
| 137 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87524671 |
| 138 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.87524671 |
| 139 | natural killer cell activation (GO:0030101) | 2.87404707 |
| 140 | reactive oxygen species biosynthetic process (GO:1903409) | 2.87075823 |
| 141 | T cell activation involved in immune response (GO:0002286) | 2.86920629 |
| 142 | myeloid leukocyte activation (GO:0002274) | 2.85629208 |
| 143 | regulation of T cell tolerance induction (GO:0002664) | 2.85612063 |
| 144 | T cell costimulation (GO:0031295) | 2.85406328 |
| 145 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.85274864 |
| 146 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.85162004 |
| 147 | regulation of T-helper 1 type immune response (GO:0002825) | 2.84074739 |
| 148 | detection of external biotic stimulus (GO:0098581) | 2.83798130 |
| 149 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.83778616 |
| 150 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.83758580 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.83758580 |
| 152 | eosinophil migration (GO:0072677) | 2.82925485 |
| 153 | regulation of mononuclear cell migration (GO:0071675) | 2.82824751 |
| 154 | regulation of germinal center formation (GO:0002634) | 2.82363427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.82945836 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.29475054 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.94773371 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.87744505 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.54731100 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.25397971 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.90952036 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.76399939 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.54540676 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49883551 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.34401286 |
| 12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.14922938 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10772215 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.88541670 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78234984 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68523648 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52657018 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48069799 |
| 19 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38865861 |
| 20 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36849508 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.33813918 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.17384239 |
| 23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05463158 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 1.99536985 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.98057889 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.93612730 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.91787922 |
| 28 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.87750858 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81660291 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.74807333 |
| 31 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.67545773 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65722301 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61152465 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58723495 |
| 35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.54864851 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54196447 |
| 37 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53998916 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53196955 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.51347639 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47538813 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.46205724 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46120917 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42960905 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.42214395 |
| 45 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38799376 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32812601 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32535254 |
| 48 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31005107 |
| 49 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29745725 |
| 50 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27585863 |
| 51 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.24813785 |
| 52 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21257233 |
| 53 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20035038 |
| 54 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19741275 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19473934 |
| 56 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16098271 |
| 57 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13145011 |
| 58 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13144450 |
| 59 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11168619 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10764482 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08455204 |
| 62 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05034020 |
| 63 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04778579 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04575453 |
| 65 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04376260 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04146997 |
| 67 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.03847215 |
| 68 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.03310985 |
| 69 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.03310985 |
| 70 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02481253 |
| 71 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02481253 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00298423 |
| 73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99633992 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98131003 |
| 75 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95994155 |
| 76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95909765 |
| 77 | CJUN_26792858_Chip-Seq_BT549_Human | 0.95768775 |
| 78 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95760962 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95024086 |
| 80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94695322 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93708170 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.93590235 |
| 83 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92271293 |
| 84 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91333962 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91269797 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88743617 |
| 87 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87340053 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86482264 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86094595 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85327723 |
| 91 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84574849 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84455616 |
| 93 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84340173 |
| 94 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84221557 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.83863945 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83862916 |
| 97 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83766904 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83376305 |
| 99 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82904147 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82348707 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82025065 |
| 102 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80813035 |
| 103 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78274166 |
| 104 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77990633 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77074680 |
| 106 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.76463428 |
| 107 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76384405 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74792614 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73767616 |
| 110 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72852771 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.72213515 |
| 112 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.71312183 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71299590 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71175543 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.71018143 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70886367 |
| 117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.70565823 |
| 118 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.70414802 |
| 119 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70186048 |
| 120 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69815888 |
| 121 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68145716 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.65107534 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.64060306 |
| 124 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.60038841 |
| 125 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.59698000 |
| 126 | GATA1_22025678_ChIP-Seq_K562_Human | 0.59441076 |
| 127 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.58932551 |
| 128 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.58222064 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.58142285 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.57684668 |
| 131 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.57601146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.19465093 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 4.25855537 |
| 3 | MP0009785_altered_susceptibility_to | 3.92644484 |
| 4 | MP0003436_decreased_susceptibility_to | 3.78091602 |
| 5 | MP0005671_abnormal_response_to | 3.64078117 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.33645458 |
| 7 | MP0000685_abnormal_immune_system | 3.28552161 |
| 8 | MP0001790_abnormal_immune_system | 3.26149704 |
| 9 | MP0005387_immune_system_phenotype | 3.26149704 |
| 10 | MP0006082_CNS_inflammation | 2.92246683 |
| 11 | MP0002419_abnormal_innate_immunity | 2.86821250 |
| 12 | MP0005025_abnormal_response_to | 2.85363818 |
| 13 | MP0003724_increased_susceptibility_to | 2.74677804 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.74219764 |
| 15 | MP0001800_abnormal_humoral_immune | 2.66983392 |
| 16 | MP0002723_abnormal_immune_serum | 2.63223209 |
| 17 | MP0001819_abnormal_immune_cell | 2.43477382 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.39781270 |
| 19 | MP0004510_myositis | 2.35826916 |
| 20 | MP0002006_tumorigenesis | 2.32055469 |
| 21 | MP0001853_heart_inflammation | 2.17604401 |
| 22 | MP0002405_respiratory_system_inflammati | 2.15608839 |
| 23 | MP0002163_abnormal_gland_morphology | 2.03649852 |
| 24 | MP0003763_abnormal_thymus_physiology | 1.99531534 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.96694492 |
| 26 | MP0005310_abnormal_salivary_gland | 1.95557802 |
| 27 | MP0003303_peritoneal_inflammation | 1.95453230 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.92633272 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.85715606 |
| 30 | MP0009764_decreased_sensitivity_to | 1.84977189 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.84142118 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.82552675 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.81666598 |
| 34 | MP0003448_altered_tumor_morphology | 1.81538871 |
| 35 | MP0000716_abnormal_immune_system | 1.75225896 |
| 36 | MP0002254_reproductive_system_inflammat | 1.73217245 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.71345541 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.70695983 |
| 39 | MP0004947_skin_inflammation | 1.68644809 |
| 40 | MP0002398_abnormal_bone_marrow | 1.66335663 |
| 41 | MP0000858_altered_metastatic_potential | 1.60686999 |
| 42 | MP0004782_abnormal_surfactant_physiolog | 1.59804480 |
| 43 | MP0001346_abnormal_lacrimal_gland | 1.56240228 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.52753461 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.45943693 |
| 46 | MP0002009_preneoplasia | 1.41561477 |
| 47 | MP0004381_abnormal_hair_follicle | 1.39915552 |
| 48 | MP0008469_abnormal_protein_level | 1.35585934 |
| 49 | MP0002429_abnormal_blood_cell | 1.31698189 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.28708349 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.24577997 |
| 52 | MP0002722_abnormal_immune_system | 1.21503938 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.15863205 |
| 54 | MP0002933_joint_inflammation | 1.15621900 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.15595248 |
| 56 | MP0000343_altered_response_to | 1.14408155 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.05832976 |
| 58 | MP0003075_altered_response_to | 1.04469795 |
| 59 | MP0003186_abnormal_redox_activity | 1.03427787 |
| 60 | MP0005390_skeleton_phenotype | 1.02410590 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.01241869 |
| 62 | MP0005166_decreased_susceptibility_to | 1.00893929 |
| 63 | MP0003828_pulmonary_edema | 0.99987235 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 0.99855893 |
| 65 | MP0001545_abnormal_hematopoietic_system | 0.99855893 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 0.99401065 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 0.99252954 |
| 68 | MP0003183_abnormal_peptide_metabolism | 0.99229018 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 0.93319191 |
| 70 | MP0009763_increased_sensitivity_to | 0.86169267 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.86168440 |
| 72 | MP0003045_fibrosis | 0.85698267 |
| 73 | MP0000703_abnormal_thymus_morphology | 0.85576374 |
| 74 | MP0009840_abnormal_foam_cell | 0.85218172 |
| 75 | MP0000604_amyloidosis | 0.83793696 |
| 76 | MP0008961_abnormal_basal_metabolism | 0.83323955 |
| 77 | MP0001663_abnormal_digestive_system | 0.82849475 |
| 78 | MP0005164_abnormal_response_to | 0.82031661 |
| 79 | MP0009278_abnormal_bone_marrow | 0.79969278 |
| 80 | MP0001851_eye_inflammation | 0.77412057 |
| 81 | MP0001873_stomach_inflammation | 0.76661054 |
| 82 | MP0002132_abnormal_respiratory_system | 0.75831998 |
| 83 | MP0000249_abnormal_blood_vessel | 0.75546848 |
| 84 | MP0003866_abnormal_defecation | 0.74896725 |
| 85 | MP0001879_abnormal_lymphatic_vessel | 0.74384322 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.73759677 |
| 87 | MP0008004_abnormal_stomach_pH | 0.73217926 |
| 88 | MP0003690_abnormal_glial_cell | 0.70847634 |
| 89 | MP0003091_abnormal_cell_migration | 0.69273339 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.69148213 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.68948323 |
| 92 | MP0003795_abnormal_bone_structure | 0.68375130 |
| 93 | MP0005451_abnormal_body_composition | 0.67574096 |
| 94 | MP0000627_abnormal_mammary_gland | 0.64790271 |
| 95 | MP0003941_abnormal_skin_development | 0.64665894 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.63885269 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.63060596 |
| 98 | MP0004130_abnormal_muscle_cell | 0.62904978 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.62681286 |
| 100 | MP0008057_abnormal_DNA_replication | 0.62638134 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.62495553 |
| 102 | MP0000371_diluted_coat_color | 0.62091272 |
| 103 | MP0001986_abnormal_taste_sensitivity | 0.60930198 |
| 104 | MP0001881_abnormal_mammary_gland | 0.60826817 |
| 105 | MP0001919_abnormal_reproductive_system | 0.60744959 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.59748038 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.59240758 |
| 108 | MP0003300_gastrointestinal_ulcer | 0.58278397 |
| 109 | MP0004883_abnormal_blood_vessel | 0.57950877 |
| 110 | MP0000490_abnormal_crypts_of | 0.56959121 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.56755746 |
| 112 | MP0000372_irregular_coat_pigmentation | 0.55760346 |
| 113 | MP0002928_abnormal_bile_duct | 0.54748911 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.53371761 |
| 115 | MP0000569_abnormal_digit_pigmentation | 0.53368815 |
| 116 | MP0010307_abnormal_tumor_latency | 0.53304040 |
| 117 | MP0003252_abnormal_bile_duct | 0.53048878 |
| 118 | MP0001191_abnormal_skin_condition | 0.52989967 |
| 119 | MP0008874_decreased_physiological_sensi | 0.51648716 |
| 120 | MP0005535_abnormal_body_temperature | 0.50942697 |
| 121 | MP0009765_abnormal_xenobiotic_induced | 0.48874289 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.47738395 |
| 123 | MP0008260_abnormal_autophagy | 0.47400765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.47909598 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.11907078 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.58748831 |
| 4 | Increased IgM level (HP:0003496) | 5.22880703 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.15861422 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 4.96908490 |
| 7 | Optic neuritis (HP:0100653) | 4.96908490 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.86996589 |
| 9 | Autoimmune thrombocytopenia (HP:0001973) | 4.68865184 |
| 10 | Orchitis (HP:0100796) | 4.59997352 |
| 11 | Myositis (HP:0100614) | 4.56536562 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.39041385 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.17001822 |
| 14 | Abnormality of T cell number (HP:0011839) | 3.97283971 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.96256918 |
| 16 | Vasculitis (HP:0002633) | 3.86082087 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 3.58149053 |
| 18 | Recurrent skin infections (HP:0001581) | 3.57426759 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.50570401 |
| 20 | Obstructive lung disease (HP:0006536) | 3.50570401 |
| 21 | Gastrointestinal stroma tumor (HP:0100723) | 3.49966922 |
| 22 | Gingivitis (HP:0000230) | 3.47987844 |
| 23 | Stomatitis (HP:0010280) | 3.46502663 |
| 24 | T lymphocytopenia (HP:0005403) | 3.42128811 |
| 25 | Pulmonary infiltrates (HP:0002113) | 3.41744657 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.40632767 |
| 27 | Increased IgE level (HP:0003212) | 3.30997751 |
| 28 | Recurrent viral infections (HP:0004429) | 3.23267128 |
| 29 | Prostate neoplasm (HP:0100787) | 3.19662909 |
| 30 | Basal ganglia calcification (HP:0002135) | 3.11520200 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.11058147 |
| 32 | Arterial thrombosis (HP:0004420) | 3.02055718 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01958445 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01958445 |
| 35 | Meningitis (HP:0001287) | 2.99866480 |
| 36 | Hypergammaglobulinemia (HP:0010702) | 2.88092189 |
| 37 | Keratoconjunctivitis (HP:0001096) | 2.87293705 |
| 38 | Verrucae (HP:0200043) | 2.86037200 |
| 39 | Papilloma (HP:0012740) | 2.86037200 |
| 40 | Leukocytosis (HP:0001974) | 2.85760586 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.85333205 |
| 42 | Hemoptysis (HP:0002105) | 2.84945190 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.84874862 |
| 44 | Recurrent sinusitis (HP:0011108) | 2.83699695 |
| 45 | Abnormality of B cell number (HP:0010975) | 2.80037044 |
| 46 | IgM deficiency (HP:0002850) | 2.78272999 |
| 47 | Thyroiditis (HP:0100646) | 2.73842275 |
| 48 | Periodontitis (HP:0000704) | 2.70934129 |
| 49 | Pustule (HP:0200039) | 2.68596051 |
| 50 | Thick nail (HP:0001805) | 2.67145273 |
| 51 | Cellulitis (HP:0100658) | 2.67035949 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.66805807 |
| 53 | Autoimmune hemolytic anemia (HP:0001890) | 2.64315251 |
| 54 | Chest pain (HP:0100749) | 2.63868276 |
| 55 | Abnormality of eosinophils (HP:0001879) | 2.58868703 |
| 56 | B lymphocytopenia (HP:0010976) | 2.58175366 |
| 57 | Eosinophilia (HP:0001880) | 2.57931352 |
| 58 | Abnormality of T cells (HP:0002843) | 2.57196590 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.56994731 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.54869317 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 2.54735021 |
| 62 | Joint swelling (HP:0001386) | 2.51169043 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46565989 |
| 64 | Pulmonary embolism (HP:0002204) | 2.44878518 |
| 65 | Combined immunodeficiency (HP:0005387) | 2.43901304 |
| 66 | Restrictive lung disease (HP:0002091) | 2.43312642 |
| 67 | IgG deficiency (HP:0004315) | 2.42575244 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.39531496 |
| 69 | Abnormality of the prostate (HP:0008775) | 2.39022157 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.36929396 |
| 71 | IgA deficiency (HP:0002720) | 2.34461579 |
| 72 | Hematochezia (HP:0002573) | 2.33519649 |
| 73 | Emphysema (HP:0002097) | 2.32464506 |
| 74 | Osteomyelitis (HP:0002754) | 2.27523105 |
| 75 | Myocardial infarction (HP:0001658) | 2.26721962 |
| 76 | Bronchitis (HP:0012387) | 2.26505023 |
| 77 | Abnormality of the pericardium (HP:0001697) | 2.23633654 |
| 78 | Chronic otitis media (HP:0000389) | 2.20985617 |
| 79 | Arthralgia (HP:0002829) | 2.20741791 |
| 80 | Gangrene (HP:0100758) | 2.20643661 |
| 81 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.19828160 |
| 82 | Encephalitis (HP:0002383) | 2.19535473 |
| 83 | Chronic diarrhea (HP:0002028) | 2.19417662 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.18602823 |
| 85 | Axonal loss (HP:0003447) | 2.18529424 |
| 86 | Recurrent bronchitis (HP:0002837) | 2.17887583 |
| 87 | Prolonged bleeding time (HP:0003010) | 2.17590995 |
| 88 | Urticaria (HP:0001025) | 2.17425785 |
| 89 | Spinal cord lesions (HP:0100561) | 2.13380017 |
| 90 | Syringomyelia (HP:0003396) | 2.13380017 |
| 91 | Anorexia (HP:0002039) | 2.13077838 |
| 92 | Granulocytopenia (HP:0001913) | 2.11238301 |
| 93 | Gingival bleeding (HP:0000225) | 2.10260549 |
| 94 | Chronic sinusitis (HP:0011109) | 2.10117555 |
| 95 | Anhidrosis (HP:0000970) | 2.08428405 |
| 96 | Epistaxis (HP:0000421) | 2.08367547 |
| 97 | Episodic fever (HP:0001954) | 2.07767356 |
| 98 | Sepsis (HP:0100806) | 2.07670488 |
| 99 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05962403 |
| 100 | Premature loss of primary teeth (HP:0006323) | 2.05933281 |
| 101 | Papilledema (HP:0001085) | 2.04770554 |
| 102 | Abnormality of the pleura (HP:0002103) | 2.02040229 |
| 103 | Petechiae (HP:0000967) | 2.01818992 |
| 104 | Tetraparesis (HP:0002273) | 2.00492545 |
| 105 | Nasal polyposis (HP:0100582) | 1.99984915 |
| 106 | Hypochromic anemia (HP:0001931) | 1.99141825 |
| 107 | Vertebral compression fractures (HP:0002953) | 1.98690690 |
| 108 | Skin rash (HP:0000988) | 1.98144648 |
| 109 | Lymphoma (HP:0002665) | 1.97938881 |
| 110 | Glomerulopathy (HP:0100820) | 1.96874527 |
| 111 | Osteolytic defects of the hand bones (HP:0009699) | 1.96785523 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96785523 |
| 113 | Keratitis (HP:0000491) | 1.96449596 |
| 114 | Polyneuropathy (HP:0001271) | 1.95240162 |
| 115 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94453377 |
| 116 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94453377 |
| 117 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94453377 |
| 118 | Spontaneous hematomas (HP:0007420) | 1.93136148 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.92653590 |
| 120 | Lymphopenia (HP:0001888) | 1.90952796 |
| 121 | Stomach cancer (HP:0012126) | 1.90287137 |
| 122 | Poor head control (HP:0002421) | 1.87665705 |
| 123 | Alveolar cell carcinoma (HP:0006519) | 1.86747430 |
| 124 | Porencephaly (HP:0002132) | 1.85964817 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85697692 |
| 126 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82485686 |
| 127 | Skin ulcer (HP:0200042) | 1.82278113 |
| 128 | Colitis (HP:0002583) | 1.82222237 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.80974376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 6.16157806 |
| 2 | TXK | 3.44456876 |
| 3 | TBK1 | 3.23997463 |
| 4 | IRAK4 | 3.09001010 |
| 5 | RIPK4 | 3.07083618 |
| 6 | IKBKB | 2.97972460 |
| 7 | JAK3 | 2.87276227 |
| 8 | IRAK3 | 2.77064810 |
| 9 | IKBKE | 2.76331676 |
| 10 | MAP4K1 | 2.49722276 |
| 11 | CHUK | 2.45527497 |
| 12 | PBK | 2.43313193 |
| 13 | TYK2 | 2.39167436 |
| 14 | MST4 | 2.33965678 |
| 15 | PIM2 | 2.33931485 |
| 16 | FES | 2.11428988 |
| 17 | BLK | 2.04091109 |
| 18 | JAK1 | 2.02504250 |
| 19 | BMPR2 | 1.96951784 |
| 20 | PIM1 | 1.55837792 |
| 21 | ERBB3 | 1.55387358 |
| 22 | NLK | 1.51310257 |
| 23 | NEK9 | 1.49928034 |
| 24 | SIK3 | 1.48731207 |
| 25 | SIK2 | 1.45481626 |
| 26 | MAP3K13 | 1.36999038 |
| 27 | TEC | 1.32839754 |
| 28 | ITK | 1.31422871 |
| 29 | CSK | 1.29691425 |
| 30 | ZAP70 | 1.26705935 |
| 31 | SYK | 1.22282270 |
| 32 | BTK | 1.19068819 |
| 33 | NUAK1 | 1.18563723 |
| 34 | TNK2 | 1.13788830 |
| 35 | FGFR3 | 1.12498535 |
| 36 | TRPM7 | 1.08217414 |
| 37 | ZAK | 1.07472708 |
| 38 | RPS6KA4 | 1.05877693 |
| 39 | EIF2AK2 | 1.04770846 |
| 40 | MAP2K2 | 1.03703143 |
| 41 | EPHA3 | 1.01668369 |
| 42 | PASK | 1.01636258 |
| 43 | LCK | 1.01537930 |
| 44 | IRAK1 | 1.01005407 |
| 45 | BCR | 0.99185987 |
| 46 | EPHB1 | 0.98981785 |
| 47 | STK4 | 0.98840398 |
| 48 | HCK | 0.96761963 |
| 49 | STK24 | 0.92665556 |
| 50 | IRAK2 | 0.91463922 |
| 51 | BMX | 0.91259869 |
| 52 | YES1 | 0.90844795 |
| 53 | TAOK1 | 0.90632066 |
| 54 | CAMKK2 | 0.89644742 |
| 55 | MARK3 | 0.87858099 |
| 56 | LYN | 0.87795495 |
| 57 | TESK2 | 0.87486441 |
| 58 | CLK1 | 0.85025016 |
| 59 | HIPK2 | 0.84695550 |
| 60 | MAP3K3 | 0.84569492 |
| 61 | NME2 | 0.84488868 |
| 62 | FGR | 0.84254150 |
| 63 | JAK2 | 0.80996296 |
| 64 | MOS | 0.80137035 |
| 65 | TGFBR2 | 0.78757343 |
| 66 | BMPR1B | 0.78545407 |
| 67 | KIT | 0.77894301 |
| 68 | FGFR4 | 0.76794458 |
| 69 | PRKCQ | 0.75907487 |
| 70 | ABL2 | 0.75340314 |
| 71 | CAMKK1 | 0.73879997 |
| 72 | PDK1 | 0.72013814 |
| 73 | MAPK12 | 0.70665242 |
| 74 | PRKCD | 0.67069606 |
| 75 | TAOK3 | 0.66300459 |
| 76 | STK10 | 0.65489192 |
| 77 | MAPK15 | 0.64443636 |
| 78 | MARK2 | 0.62233587 |
| 79 | DYRK1B | 0.58754289 |
| 80 | PRKD2 | 0.58366396 |
| 81 | ABL1 | 0.56485704 |
| 82 | NEK6 | 0.55845930 |
| 83 | MAPKAPK2 | 0.55510107 |
| 84 | MAPK11 | 0.55393963 |
| 85 | STK3 | 0.55143532 |
| 86 | ADRBK2 | 0.54741675 |
| 87 | MAP3K7 | 0.54032894 |
| 88 | GRK7 | 0.53282132 |
| 89 | KSR2 | 0.51034632 |
| 90 | MAP3K11 | 0.48763776 |
| 91 | FYN | 0.48421539 |
| 92 | FRK | 0.48057260 |
| 93 | MAP3K10 | 0.47440524 |
| 94 | SIK1 | 0.47421593 |
| 95 | CDC42BPA | 0.47043779 |
| 96 | DMPK | 0.46582580 |
| 97 | ARAF | 0.46450026 |
| 98 | SGK2 | 0.45215713 |
| 99 | TLK1 | 0.41994777 |
| 100 | INSRR | 0.41369152 |
| 101 | MST1R | 0.40021177 |
| 102 | MAP2K3 | 0.39812576 |
| 103 | MAP3K5 | 0.39646628 |
| 104 | PRPF4B | 0.39398721 |
| 105 | MAP3K12 | 0.39274375 |
| 106 | TESK1 | 0.38888789 |
| 107 | MAPK4 | 0.38039182 |
| 108 | CDK4 | 0.37715718 |
| 109 | PIK3CG | 0.37554178 |
| 110 | RPS6KC1 | 0.37311351 |
| 111 | RPS6KL1 | 0.37311351 |
| 112 | MAP4K2 | 0.36578189 |
| 113 | SGK3 | 0.36279605 |
| 114 | CSF1R | 0.35413468 |
| 115 | PDPK1 | 0.34397734 |
| 116 | RPS6KA6 | 0.33945015 |
| 117 | RPS6KA5 | 0.32121235 |
| 118 | TYRO3 | 0.31355040 |
| 119 | PTK6 | 0.29800711 |
| 120 | PKN1 | 0.29630515 |
| 121 | IGF1R | 0.29246765 |
| 122 | PRKCH | 0.28982905 |
| 123 | RPS6KA1 | 0.28027613 |
| 124 | BRD4 | 0.27511426 |
| 125 | MATK | 0.26663227 |
| 126 | CDK6 | 0.26563179 |
| 127 | GRK6 | 0.26007733 |
| 128 | RIPK1 | 0.25694236 |
| 129 | TAOK2 | 0.25522414 |
| 130 | EGFR | 0.24289331 |
| 131 | PDGFRB | 0.23272613 |
| 132 | MAPK7 | 0.22713598 |
| 133 | MAP3K1 | 0.22350264 |
| 134 | INSR | 0.22329190 |
| 135 | GSK3A | 0.18676426 |
| 136 | ERN1 | 0.18003075 |
| 137 | PRKCE | 0.17761613 |
| 138 | MAPK3 | 0.17385352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.40573032 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.95434650 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87962066 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.83021975 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77155095 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58687271 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.55878558 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.47331811 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.46483506 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.43540969 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39050199 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.32707140 |
| 13 | Measles_Homo sapiens_hsa05162 | 2.26515779 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.12546036 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08432553 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02526800 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.94842099 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94512270 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.93538934 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.91148656 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80344081 |
| 22 | Pertussis_Homo sapiens_hsa05133 | 1.77275370 |
| 23 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.73399022 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.72804096 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.70214686 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.62375320 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58880051 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.56412287 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55601361 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54282149 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51072313 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50801662 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45399959 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.45138584 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42622376 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40656870 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.33830114 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30818265 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29246660 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.19308310 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.11409268 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.04114521 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02880929 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93683436 |
| 45 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89967695 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 0.87779681 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.87050290 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.86745997 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79495000 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77544975 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75519805 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74117927 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72111429 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67922706 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65183003 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64071434 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.63501895 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63114794 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61396795 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60662541 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60097839 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57843068 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56390685 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55642156 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54267939 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53282613 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51378757 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.50557755 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49462405 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48535475 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48508736 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46767570 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.46369027 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45489306 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44362623 |
| 76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43391605 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.43356094 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.42294166 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41430185 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41370901 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41023213 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39895216 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.38745487 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38150346 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.36561981 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36277029 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35618814 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34597508 |
| 89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33754005 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32802573 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32058689 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31799372 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29395903 |
| 94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29356238 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28367653 |
| 96 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28342549 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.27693316 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.26929629 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26410341 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25644552 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25389978 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.25229568 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23420395 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23180775 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21801764 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.21068095 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20723810 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20413910 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.19640650 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17427485 |
| 111 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15939715 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13621166 |
| 113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.12596714 |
| 114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.11681694 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.11584283 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.10748164 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.10694548 |
| 118 | Protein export_Homo sapiens_hsa03060 | 0.08812740 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.08804230 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.08521418 |
| 121 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.06456897 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.06256456 |

